MCM10 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 1.40489841982117E-11 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.49330000001713E-06 |
Normal-vs-Stage2 |
5.391900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
2.159200E-03 |
Stage1-vs-Stage2 |
8.520600E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
5.676200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
4.302200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
6.28739948993484E-10 |
Normal-vs-AfricanAmerican |
2.104200E-01 |
Normal-vs-Asian |
7.301900E-02 |
Caucasian-vs-AfricanAmerican |
4.833400E-01 |
Caucasian-vs-Asian |
5.704400E-01 |
AfricanAmerican-vs-Asian |
3.357800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.77860000000396E-05 |
Normal-vs-Female |
7.05160000391558E-08 |
Male-vs-Female |
4.684600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
6.827900E-04 |
Normal-vs-Extreme_Weight |
2.27229999999468E-05 |
Normal-vs-Obese |
1.902650E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.056200E-01 |
Normal_Weight-vs-Obese |
2.880600E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.001820E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.049800E-02 |
Normal-vs-Age(41-60Yrs) |
1.021270E-03 |
Normal-vs-Age(61-80Yrs) |
9.87770000238086E-08 |
Normal-vs-Age(81-100Yrs) |
3.381000E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.973600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.486800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.561400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.434400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.371800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.620400E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
7.227600E-01 |
Normal-vs-Grade 3 |
4.530600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.559770E-02 |
Grade 2-vs-Grade 4 |
7.227600E-01 |
Grade 3-vs-Grade 4 |
4.530600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.89299997899184E-09 |
Normal-vs-N1 |
6.161000E-03 |
N0-vs-N1 |
7.681400E-01 |
|
|